ReviewDiabetes, metabolic syndrome and obesity : targets and therapy2025

The Emerging Role of Anti-Hyperglycemic Agents for the Management of Metabolic Dysfunction-Associated Steatotic Liver Disease.

Silvia Pieralice et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.